Australian drug prices low by world standards A new report has found Australians are paying among the lowest prices in the world for generic prescription drugs.
Pharmacy-led study promotes minor ailments scheme The initiative would see some people transferred from GPs to community pharmacies as early as next year.
Six core areas of NDIS plan revealed Final stages of the NDIS overhaul come after reviews of the process revealed major improvements are needed.
Cystic fibrosis drug listed on PBS While the announcement was welcomed, some have questioned the seven month delay between approval and listing.
Pharmaceutical Benefits Advisory Council responds to criticism Chair Andrew Wilson said suggestions of delayed approvals are not new and Australia has one of ‘the fastest systems in the world’.
NDIS underspend continues The Government has now spent $4.6 billion less on the scheme than originally anticipated, with the savings put towards the Budget bottom line.
NDIS review to streamline processes The Federal Government has announced a thorough assessment of the scheme, designed to cut red tape and reduce wait times.
Cancer and inflammatory disease medicines receive $56 million boost Four new medicines will be listed through the Pharmaceutical Benefits Scheme, helping patients fight aggressive cancers and inflammatory conditions.
Access to cystic fibrosis medication expanded Children aged 12–24 months with a rare form of the genetic disorder will soon be eligible to receive subsidised medication, saving their families up to $300,000 per year.
GPs’ role in linking patients with the NDIS The new RACGP resource can help assess patient eligibility for the NDIS and give information on how to access it.